[1]
Llerena-Velastegui, J., Delgado-Quijano, F., Trujillo-Delgado, M., Villacis-Lopez, C., Fernandez-Arcos, A., Santafe-Abril, G., Hurtado-Alzate, C. and Benitez-Acosta, K. 2023. Comparative Efficacy of Tirzepatide, Teneligliptin, and Empagliflozin in HbA1c Reduction in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis. International Journal of Medical and Surgical Sciences. 10, 3 (Sep. 2023), 1–18. DOI:https://doi.org/10.32457/ijmss.v10i3.2263.